Form 4: Guardant Health Director Steve Krognes Reports Stock Transactions
SEC Form 4 Filing
Director Steve Krognes reported the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.
Summary
- On June 30, 2024, Steve Krognes, a director of Guardant Health, Inc., reported a transaction involving restricted stock units.
- 154 restricted stock units vested and were converted into 154 shares of common stock.
- Following the transaction, Krognes directly owns 9,294 shares of common stock and 3,703 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company director, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction may have a minor dilutive effect on existing shareholders due to the issuance of new shares.
Key Dates
| Date | Description |
|---|---|
| August 9, 2022 | Date of grant for the restricted stock unit award. |
| June 30, 2023 | First vesting date for 25% of the restricted stock units. |
| June 30, 2024 | Date of the reported transaction where restricted stock units vested and converted to common stock. |
| July 02, 2024 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.